Clinical reference Biomarker Directory
Back to directory

TNNT2

Established

Cardiac troponin T is clinically equivalent to troponin I as a gold-standard heart attack diagnostic biomarker.

Also known as Cardiac troponin T cTnT hs-cTnT
In plain language

Troponin T works the same way as troponin I for diagnosing heart attacks — hospitals typically use one or the other as their standard test, not both. Tracking how the level changes over a few hours, not just a single number, is often what really confirms whether a heart attack is happening right now.

Biomarker & context

TNNT2 encodes cardiac troponin T, the other of the two current gold-standard biomarkers (with troponin I) for diagnosing myocardial injury and heart attacks.

What it indicates

Elevated cardiac troponin T indicates myocardial injury, interpreted identically to troponin I within the universal definition of myocardial infarction; the two troponins (T and I) are generally considered clinically interchangeable for diagnostic purposes, though a given hospital typically uses one or the other, not both routinely.

Diagnosis & clinical testing

As with troponin I, high-sensitivity troponin T assays use the assay-specific 99th percentile as the diagnostic threshold, with 0/1-hour or 0/3-hour rapid algorithms in wide clinical use; the same lack of a universal cutoff and need for sex-specific reference limits applies equally here.

Guiding treatment

Serial (delta) troponin T measurements distinguish acute from chronic myocardial injury, since a rising or falling pattern over serial draws indicates an acute process, while a stable elevated level suggests chronic structural heart disease rather than an acute event.

Clinical significance

Serial (delta) measurements help distinguish acute from chronic myocardial injury patterns.

References
  1. AAFP. (2024). High-Sensitivity Troponin in the Diagnosis of Acute Coronary Syndrome.